1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Community and Civil Society Engagement Pilot for Lenacapavir is sponsored by Various, likely through global health initiatives. This pilot program provides grant funding to community-based and civil society organizations in Sub-Saharan Africa, including Somalia, to strengthen community participation in the introduction and scale-up of lenacapavir.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Community and Civil Society Engagement (CCSE) Pilot for Lenacapavir - Wits RHI Skip to primary navigation Supporting Community-Led Action for Equitable Access to New HIV Prevention Options Community and Civil Society Engagement (CCSE) Pilot for Lenacapavir Applications are Now Open Expression of Interest Deadline: 28 August 2026, 23:59hrs SAST Download Applicant Guidelines , Download Expression of Interest (EOI) Unitaid is funding a Community and Civil Society Engagement (CCSE) Pilot for lenacapavir (LEN) a groundbreaking long-acting HIV prevention innovation with the potential to expand choice and transform access for communities most affected by HIV.
Implemented in partnership with Wits RHI University of the Witwatersrand and the Clinton Health Access Initiative (CHAI) , the pilot aims to strengthen the role of communities and civil society organisations as key partners in the introduction and scale-up of new HIV prevention technologies.
The CCSE Pilot builds on the strong foundation of community engagement established through Wits RHI’s Project PrEP , which has supported community consultation, prevention literacy, demand generation, civil society participation and the integration of community perspectives into HIV prevention programmes and decision-making.
Through this work, community organisations have helped identify barriers to access, inform implementation approaches and advocate for more person-centred prevention services. The CCSE Pilot seeks to build on this foundation by testing new ways to directly support community-based and civil society organisations, enabling them to play an even more active role in supporting the successful and equitable introduction of lenacapavir.
Learn more about Project PrEP Why Community Leadership Matters For new health technologies to achieve their full impact, they must be trusted, understood and accessible to the people who need them most.
Community and civil society organisations play a critical role in: Building awareness and prevention literacy Generating demand and fostering trust Identifying and addressing barriers to access Holding programmes accountable to community needs Amplifying the voices of populations most affected by HIV By strengthening community leadership and engagement, the CCSE Pilot will generate practical lessons on how best to resource and partner with communities to support equitable and sustainable access to new HIV prevention options.
What Is the CCSE Pilot Looking For? The CCSE Pilot is looking for organisations with strong community connections, relevant experience and ideas that can make a meaningful difference.
We are seeking organisations with: Strong ties to the communities they serve Practical and innovative ideas A demonstrated commitment to community leadership and participation The ability to contribute to equitable lenacapavir introduction and uptake The CCSE Pilot has two complementary objectives. 1.
Strengthen Community-Led Action Support community and civil society organisations to lead advocacy, accountability, community engagement, prevention literacy and demand-generation efforts during the early introduction of lenacapavir. Generate practical, decision-relevant learning on how to more effectively fund and support community-led action within Unitaid-supported health innovations.
The pilot will test approaches that: Directly resource community and civil society actors Expand access to funding for grassroots organisations Simplify funding processes and reduce barriers to participation Support community-led advocacy, accountability, engagement and demand generation during LEN introduction A total funding envelope of up to USD 200,000 is available through the CCSE Pilot.
To maximise learning across diverse settings and approaches, funding may be awarded to multiple organisations. Applicants should therefore not assume that the full funding amount will be awarded to a single project. We welcome applications from organisations that are deeply connected to the communities they serve and are committed to advancing equitable access to HIV prevention.
Eligible applicants include: Community-based organisations (CBOs) Civil society organisations (CSOs) Intermediary organisations that are legally registered or formally recognised Organisations should also: Have strong, meaningful relationships with and accountability to affected communities.
Be working in a Sub-Saharan African country that has introduced lenacapavir or has confirmed plans to introduce it through national programmes in the near future. Demonstrate experience in areas such as community engagement, advocacy, accountability, HIV prevention, sexual and reproductive health, or related health fields. The application process has been designed to be accessible and manageable, particularly for smaller organisations.
Stage 1: Expression of Interest (EOI) Interested organisations are invited to submit a short Expression of Interest outlining their proposed idea and approach. EOI Submission Deadline: 28 August 2026, 23:59hrs SAST Stage 2: Concept Note — Invitation Only Organisations shortlisted through the EOI stage will be invited to submit a more detailed Concept Note.
Shortlisted applicants will receive templates, guidance materials and submission instructions. Applicant Information Webinar An information webinar will be held during the EOI application period.
The objectives of the CCSE Pilot The application and assessment process An introduction to lenacapavir and its role in HIV prevention The role of community and civil society organisations in supporting equitable product introduction, accountability, prevention literacy and community engagement Participation is optional and will not influence the assessment of applications.
Before submitting your application, please read the Applicant Guidelines carefully. DOWNLOAD APPLICANT GUIDELINES Complete the Expression of Interest (EOI) document and follow the submission instructions provided. DOWNLOAD EXPRESSION OF INTEREST If you still have questions after reviewing the Applicant Guidelines, prospective applicants are encouraged to submit their questions to: CCSEproposals@wrhi.
ac. za Please submit questions by 17 August 2026 . Responses to frequently asked questions may be shared with all prospective applicants to promote transparency and ensure equitable access to information.
17 August 2026: Deadline for submitting questions 28 August 2026: Expression of Interest submission deadline Submit your Expression of Interest by 28 August 2026 and help shape the introduction of one of the most significant innovations in HIV prevention.
Community and Civil Society Engagement (CCSE) Pilot for Lenacapavir Applications are Now Open Expression of Interest Deadline: 28 August 2026, 23:59hrs SAST Download Applicant Guidelines , Download Expression of Interest (EOI) Unitaid is funding a Community and Civil Society Engagement (CCSE) Pilot for lenacapavir (LEN) a groundbreaking long-acting HIV prevention innovation with the potential to expand choice and transform access for communities most affected by HIV.
Implemented in partnership with Wits RHI University of the Witwatersrand and the Clinton Health Access Initiative (CHAI) , the pilot aims to strengthen the role of communities and civil society organisations as key partners in the introduction and scale-up of new HIV prevention technologies.
The CCSE Pilot builds on the strong foundation of community engagement established through Wits RHI’s Project PrEP , which has supported community consultation, prevention literacy, demand generation, civil society participation and the integration of community perspectives into HIV prevention programmes and decision-making.
Through this work, community organisations have helped identify barriers to access, inform implementation approaches and advocate for more person-centred prevention services. The CCSE Pilot seeks to build on this foundation by testing new ways to directly support community-based and civil society organisations, enabling them to play an even more active role in supporting the successful and equitable introduction of lenacapavir.
Learn more about Project PrEP Why Community Leadership Matters For new health technologies to achieve their full impact, they must be trusted, understood and accessible to the people who need them most.
Community and civil society organisations play a critical role in: Building awareness and prevention literacy Generating demand and fostering trust Identifying and addressing barriers to access Holding programmes accountable to community needs Amplifying the voices of populations most affected by HIV By strengthening community leadership and engagement, the CCSE Pilot will generate practical lessons on how best to resource and partner with communities to support equitable and sustainable access to new HIV prevention options.
What Is the CCSE Pilot Looking For? The CCSE Pilot is looking for organisations with strong community connections, relevant experience and ideas that can make a meaningful difference.
We are seeking organisations with: Strong ties to the communities they serve Practical and innovative ideas A demonstrated commitment to community leadership and participation The ability to contribute to equitable lenacapavir introduction and uptake The CCSE Pilot has two complementary objectives. 1.
Strengthen Community-Led Action Support community and civil society organisations to lead advocacy, accountability, community engagement, prevention literacy and demand-generation efforts during the early introduction of lenacapavir. Generate practical, decision-relevant learning on how to more effectively fund and support community-led action within Unitaid-supported health innovations.
The pilot will test approaches that: Directly resource community and civil society actors Expand access to funding for grassroots organisations Simplify funding processes and reduce barriers to participation Support community-led advocacy, accountability, engagement and demand generation during LEN introduction A total funding envelope of up to USD 200,000 is available through the CCSE Pilot.
To maximise learning across diverse settings and approaches, funding may be awarded to multiple organisations. Applicants should therefore not assume that the full funding amount will be awarded to a single project. We welcome applications from organisations that are deeply connected to the communities they serve and are committed to advancing equitable access to HIV prevention.
Eligible applicants include: Community-based organisations (CBOs) Civil society organisations (CSOs) Intermediary organisations that are legally registered or formally recognised Organisations should also: Have strong, meaningful relationships with and accountability to affected communities.
Be working in a Sub-Saharan African country that has introduced lenacapavir or has confirmed plans to introduce it through national programmes in the near future. Demonstrate experience in areas such as community engagement, advocacy, accountability, HIV prevention, sexual and reproductive health, or related health fields. The application process has been designed to be accessible and manageable, particularly for smaller organisations.
Stage 1: Expression of Interest (EOI) Interested organisations are invited to submit a short Expression of Interest outlining their proposed idea and approach. EOI Submission Deadline: 28 August 2026, 23:59hrs SAST Stage 2: Concept Note — Invitation Only Organisations shortlisted through the EOI stage will be invited to submit a more detailed Concept Note.
Shortlisted applicants will receive templates, guidance materials and submission instructions. Applicant Information Webinar An information webinar will be held during the EOI application period.
The objectives of the CCSE Pilot The application and assessment process An introduction to lenacapavir and its role in HIV prevention The role of community and civil society organisations in supporting equitable product introduction, accountability, prevention literacy and community engagement Participation is optional and will not influence the assessment of applications.
Before submitting your application, please read the Applicant Guidelines carefully. DOWNLOAD APPLICANT GUIDELINES Complete the Expression of Interest (EOI) document and follow the submission instructions provided. DOWNLOAD EXPRESSION OF INTEREST If you still have questions after reviewing the Applicant Guidelines, prospective applicants are encouraged to submit their questions to: CCSEproposals@wrhi.
ac. za Please submit questions by 17 August 2026 . Responses to frequently asked questions may be shared with all prospective applicants to promote transparency and ensure equitable access to information.
17 August 2026: Deadline for submitting questions 28 August 2026: Expression of Interest submission deadline Submit your Expression of Interest by 28 August 2026 and help shape the introduction of one of the most significant innovations in HIV prevention. Established in 1994, Wits RHI is part of the Faculty of Health Sciences and a leading research institute of the University of the Witwatersrand.
According to the current listing, eligibility includes: Community-based and civil society organizations in Sub-Saharan Africa. Confirm the full requirements in the official notice before applying.
The published deadline was August 28, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Community and Civil Society Engagement Pilot for Lenacapavir is funded by Various, likely through global health initiatives. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The OpenAI Foundation is putting $100 million behind Breakthroughs to Follow-Through, a Common Health Coalition initiative aiming to at least double hepatitis C cure rates in eight states and localities within two years. Alabama, Illinois, Louisiana and Massachusetts go first, money flows to local collaboratives and nonprofits, and the grants are deliberately not tied to any one AI vendor. Here is what makes an organization fundable under it.
Read articleARPA-H's FASTPASS program targets a public-health blind spot: substandard and contaminated drugs that are only caught after patients are exposed. It funds through-package chemical sensing (TA1 SAMPLE) and the analytics to act on it (TA2 DETECT). The solicitation posts to SAM.gov in mid-August 2026, with a virtual Proposer Workshop on August 24 and registration closing August 20. Here is what FASTPASS funds, why the timing matters, and how to position a cross-disciplinary team.
Read articleA September 18, 2026 proclamation renews the $100,000 H-1B payment through September 21, 2027. Courts have blocked collection since June. The cap-exempt carve-out that protects universities from the DHS fee rule does not appear here — and that gap decides how grant-funded labs should hire.
Read article